OAC
AMRX icon

OMERS Administration Corp’s Amneal Pharmaceuticals AMRX Stock Holding History

OMERS Administration Corp’s Portfolio AMRX Stock Details AMRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-21,900
Closed -$219K – 1054
2025
Q3 		$219K Buy
+21,900
New +$197K ﹤0.01% 962
2024
Q3 		– Sell
-27,200
Closed -$173K – 902
2024
Q2 		$173K Buy
+27,200
New +$173K ﹤0.01% 907

Other funds holding AMRX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
TGA
TPG GP A Fort Worth, Texas $3.68B AUM 14.99% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

OMERS Administration Corp's AMRX Position: Q4 2025 in Review

OMERS Administration Corp sold out of Amneal Pharmaceuticals (AMRX) in Q4 2025, closing a stake of 21,900 shares — an estimated $219K sold.

OMERS Administration Corp first reported a position in AMRX in Q2 2024 and held it in 2 quarters. The position peaked at $219K in Q3 2025. 277 funds tracked by Wall St. Rank hold AMRX as of Q4 2025.

  • OMERS Administration Corp reported no remaining Amneal Pharmaceuticals position as of Q4 2025 after selling out during the quarter.
  • OMERS Administration Corp sold 21,900 Amneal Pharmaceuticals shares in Q4 2025, an estimated $219K.
  • OMERS Administration Corp first reported a position in Amneal Pharmaceuticals in Q2 2024 and held it in 2 quarters.
  • OMERS Administration Corp's Amneal Pharmaceuticals position peaked at $219K in Q3 2025.
  • 277 funds tracked by Wall St. Rank held Amneal Pharmaceuticals as of Q4 2025.

Based on OMERS Administration Corp's 13F filing for Q4 2025, filed 13 Feb 2026.